Over the past months there have been a number of cancer lawsuits filed against the popular heartburn/antacid drug Zantac (Ranitidine) and its manufacturers, due to recent findings of unsafe levels of the carcinogen N-nitrosodimethlylamine (NDMA).
New Research Confirming Ranitidine Produces High Levels of Cancer-causing Chemical when Exposed to Elevated Temperatures
There is now new research confirming that the popular heartburn medication, Zantac, has been found to produce unacceptably high levels of cancer-causing chemical, N-nitrosodimethlylamin (NDMA), when exposed to elevated temperatures during transport and storage.
Since September 2019, the U.S. Food and Drug Administration (FDA) has been monitoring the presence of this toxic chemical found in samples of Zantac, both the brand name drug and it’s generic form, Ranitidine.
During current on-going laboratory testing, it has been confirmed that production of this carcinogenic chemical, NDMA, within Ranitidine the active ingredient in Zantac, can increase to dangerous levels in as little as five days during heat exposure. This analysis suggests that the more you heat Ranitidine, the more NDMA is produced. Even limited exposure to high heat can cause this chemical production; there is worry that when the drug sits at home on a shelf at room temperature for long enough it could gradually generate NDMA production.
The testing company that published the initial results filed a petition for recall to the US Food and Drug Administration (FDA) following their September 2019 findings, and a secondary testing company that found the recent breakthrough submitted a petition in January 2020. However, the FDA has had no comment about these new findings, aside from that it will review the petition and is working with drug manufacturers to produce safe products.
It has been known since the first findings that Ranitidine can produce NDMA in the body when digested, but this new research says that the drug can go through this even before ingestion, making it even more dangerous. We know that drug manufacturers are required to test the drug before its packaging and release, but it is apparent that they didn’t bother to test what would happen from the factory to the patients’ mouths, well after the company analysis.
How Do you Qualify for Lawsuits Against Zantac/ Ranitidine?
Zantac has been widely used (and marketed as safe by manufacturers) since its introduction in 1983. Many have been treating their heartburn, indigestion, acid reflux, and similar symptoms with the drug for years or even decades. Those unfortunate enough to have developed cancer due to regular and continued use of Zantac or similar drugs are encouraged to seek compensation.
Though most drug companies have recalled their Ranitidine products, many customers are still unaware that a cancer diagnosis during in the recent past may have been caused by Zantac, as it’s been on the market since 1985.
Our fierce legal team at Kwartler Manus, LLC can help you win the money you deserve.
If you or a loved one has been diagnosed with cancer after regular Zantac use, you may be eligible to file a lawsuit and receive compensation. The cancer diagnoses listed below may qualify:
Small intestine cancer
How Can We Help?
If you or a loved one has developed cancer after using Zantac (Ranitidine), make sure to contact an experienced attorney. Do not wait! There are various deadlines and statute of limitations for cases such as this, and you don’t want to be reaching out too late.
Our dedicated attorneys have experience representing clients in similar cases. By filing/joining a mass tort claim against Zantac, you may be able to get compensation for your damages and protect others from future threats. Our attorneys will be by your side to help you navigate this complex process with ease and help you win the money you deserve.
Don’t hesitate to pursue the compensation you deserve to make up for these pharmaceutical companies’ mistakes. Contact us today to schedule a free consultation and learn your rights.